|
| PILSICAINIDE Basic information |
Product Name: | PILSICAINIDE | Synonyms: | PILSICAINIDE;PILSICAININIDE;PILSICAINIDE(FORRESEARCHONLY);N-(2,6-Dimethylphenyl)tetrahydro-1H-pyrrolizine-7α(5H)-acetamide;SUN-1165;Sunrhythm;N-(2,6-Dimethylphenyl)-2,3,6,7-tetrahydro-1H-pyrrolizine-7a(5H)-acetamide;N-(2,6-Dimethylphenyl)tetrahydro-1H-pyrrolizine-7a(5H)-acetamide | CAS: | 88069-67-4 | MF: | C17H24N2O | MW: | 272.39 | EINECS: | | Product Categories: | | Mol File: | 88069-67-4.mol | |
| PILSICAINIDE Chemical Properties |
storage temp. | Sealed in dry,2-8°C |
Hazard Codes | Xn | Risk Statements | 22 |
| PILSICAINIDE Usage And Synthesis |
Chemical Properties | Pilsicainide: C17H24N2O?HCl?1/2H20. [88069-49-2]. It is obtained from the crystallization of ethanol-diethyl ether. Odorless, bitter taste, melting point 212 ~ 214℃. It is highly soluble in glacial acetic acid and soluble in methanol, ethanol or water. | Uses | Pilsicainide is a class IC antiarrhythmic drug, suitable for the treatment of patients with ventricular tachycardia ineffective or intolerable to other antiarrhythmic drugs. | Definition | ChEBI: Pilsicainide is a secondary carboxamide resulting from the formal condensation of the amino group of 2,6-dimethylaniline with the carboxy group of (tetrahydro-1H-pyrrolizin-7a(5H)-yl)acetic acid. It is a sodium channel blocker which is used as an antiarrhythmic drug for the management of atrial tachyarrhythmias in Japan. It has a role as an anti-arrhythmia drug and a sodium channel blocker. It is a secondary carboxamide and an organic heterobicyclic compound. | Synthesis | Pilsicainide was obtained from tetrahydrodithickened pyrrole ethyl acetate and 2, 6-dimethylaniline heated and condensed in dioxane at 100℃ under the action of sodium hydride. It is also possible to hydrolyze tetrahydrodithickened pyrrole ethyl acetate and chlorinate it to tetrahydrodithickened pyrrole acetyl chloride, which is then condensed with 2, 6-dimethylaniline. |
| PILSICAINIDE Preparation Products And Raw materials |
|